Google owner Alphabet has launched an artificial intelligence company to discover new drugs.
UK-registered Isomorphic Labs will use technology from sister company DeepMind to find cures for some of humanity’s most devastating diseases.
AlphaFold2 technology could be used to predict the shape of every protein in the human body with almost perfect accuracy. Its speed could cut the time to discovering innovative treatments, although the process of clinical trials is still likely to take several years.
The company will partner with pharmaceutical and biomedical companies and hopes to use the technology to try to find treatments for Chagas disease and Leishmaniasis, two of the most deadly diseases in the world.